Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit

被引：0
|
作者：
James, Daniel [1 ]
Verigou, Eleni-Anna [1 ]
Wilson, Andrew [2 ]
O'Nions, Jenny [2 ]
Ahmed, Syeda [2 ]
Alimam, Samah [3 ]
Sekhar, Mallika [2 ]
Lambert, Jonathan [2 ]
机构：
[1] UCL, Sch Med, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2021-PO
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis
    Vigano, Ilaria
    Di Giacomo, Nunzio
    Bozzani, Sofia
    Antolini, Laura
    Piazza, Rocco
    Passerini, Carlo Gambacorti
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (10) : E184 - E187
  • [22] More robust evidence for the efficacy of lithium in the long-term treatment of bipolar disorder: should lithium (again) be recommended as the single preferred first-line treatment?
    Nolen W.A.
    International Journal of Bipolar Disorders, 3 (1)
  • [23] Second-line gemcitabine plus nab-paclitaxel (G plus A) for advanced pancreatic cancer (APC) after first-line FOLFIRINOX: Single institution retrospective review of efficacy and toxicity
    Zhang, Yue
    Hochster, Howard S.
    Stein, Stacey
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [24] Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis
    Song, Yuqin
    Zhou, Keshu
    Zou, Dehui
    Li, Dengju
    Hu, Jianda
    Yang, Haiyan
    Zhang, Huilai
    Ji, Jie
    Xu, Wei
    Jin, Jie
    Lv, Fangfang
    Feng, Ru
    Gao, Sujun
    Zhou, Daobin
    Tam, Constantine S.
    Simpson, David
    Wang, Michael
    Phillips, Tycel J.
    Opat, Stephen
    Fang, Cheng
    Sun, Shaohui
    Zhu, Jun
    CANCER MEDICINE, 2023, 12 (18): : 18643 - 18653
  • [25] Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
    Yusuf Usta
    Inci Nur Saltik-Temizel
    Hulya Demir
    Nuray Uslu
    Hasan Ozen
    Figen Gurakan
    Aysel Yuce
    Journal of Gastroenterology, 2008, 43 : 429 - 433
  • [26] Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection
    Usta, Yusuf
    Saltik-Temizel, Inci Nur
    Demir, Hulya
    Uslu, Nuray
    Ozen, Hasan
    Gurakan, Figen
    Yuce, Aysel
    JOURNAL OF GASTROENTEROLOGY, 2008, 43 (06) : 429 - 433
  • [27] Long-term efficacy of combination nivolumab and ipilimumab for first-line treatment of advanced melanoma: A network meta-analysis
    Mohr, P.
    Toor, K.
    Goring, S.
    Chan, K.
    Besada, M.
    Johnson, H. M.
    Moshyk, A.
    Kotapati, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
    Haguet, Helene
    Graux, Carlos
    Mullier, Francois
    Dogne, Jean-Michel
    Douxfils, Jonathan
    CANCERS, 2020, 12 (05)
  • [29] A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis
    Zachou, K.
    Gatselis, N. K.
    Arvaniti, P.
    Gabeta, S.
    Rigopoulou, E. I.
    Koukoulis, G. K.
    Dalekos, G. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (10) : 1035 - 1047
  • [30] A phase II single arm trial evaluating the efficacy and safety of Temozolomide for second-line treatment of neuroendocrine carcinomas progressing after first-line platinum-based therapy
    Cannella, L.
    von Arx, C.
    Bracigliano, A.
    Pizzolorusso, A.
    Antonella, D. S.
    Clemente, O.
    Modica, R.
    Di Marzo, M.
    Tatangelo, F.
    Tafuto, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 169 - 169
12345